Xiaoyu Zhang

Dr. Xiaoyu Zhang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in Chemical Reviews
Verified
Journal Article
Closed access
HJHong Jiang
Hong Jiang
XZXiaoyu Zhang
Xiaoyu Zhang
XCXiao Chen
Xiao Chen
PAPornpun Aramsangtienchai
Pornpun Aramsangtienchai
ZTZhen Tong
Zhen Tong
HLHening Lin
Hening Lin

17 June 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
XZXiaoyu Zhang
Xiaoyu Zhang
VCVincent M. Crowley
Vincent M. Crowley
TWThomas G. Wucherpfennig
Thomas G. Wucherpfennig
MDMelissa M. Dix
Melissa M. Dix
BCBenjamin F. Cravatt
Benjamin F. Cravatt

29 July 2020 in Cell
Verified
Journal Article
Closed access
EVEkaterina Vinogradova
Ekaterina Vinogradova
XZXiaoyu Zhang
Xiaoyu Zhang
DRDavid Remillard
David Remillard
DLDaniel C. Lazar
Daniel C. Lazar
RSRadu M. Suciu
Radu M. Suciu
BCBenjamin F. Cravatt
Benjamin F. Cravatt

30 March 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
XZXiaoyu Zhang
Xiaoyu Zhang
LLLena M. Luukkonen
Lena M. Luukkonen
CEChristie L. Eissler
Christie L. Eissler
VCVincent M. Crowley
Vincent M. Crowley
YYYu Yamashita
Yu Yamashita
BCBenjamin F. Cravatt
Benjamin F. Cravatt

28 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JCJi Cao
Ji Cao
LSLei Sun
Lei Sun
PAPornpun Aramsangtienchai
Pornpun Aramsangtienchai
NSNicole A. Spiegelman
Nicole A. Spiegelman
XZXiaoyu Zhang
Xiaoyu Zhang
HLHening Lin
Hening Lin
Significance: HDAC11 is the only class IV member of the histone deacetylase (HDAC) family, and very little is known about its biological function. The work here reveals its efficient and physiologically relevant activity. The regulation of SHMT2 and interferon signaling expands the known biological function of protein lysine fatty acylation, which has only recently started to be appreciated. Furthermore, a compelling molecular mechanism is proposed to connect HDAC11 to immune response. The finding opens exciting opportunities to develop HDAC11-specific inhibitors to treat human diseases that would benefit from increased type I interferon signaling, such as viral infection, multiple sclerosis, and cancer.

1 May 2019 in Developmental Cell
Verified
Journal Article
Closed access
ALArash Latifkar
Arash Latifkar
LLLu Ling
Lu Ling
AHAmrit Hingorani
Amrit Hingorani
EJEric Johansen
Eric Johansen
ACAmdiel Clement
Amdiel Clement
MAMarc A. Antonyak
Marc A. Antonyak